0224 QT Deals
BioCentury & Getty Images


Feb. 24 Quick Takes: ICON buying PRA in $12B CRO deal; plus venture rounds for Yisheng, Xilio, Truvian, Lyvgen, AmacaThera, and more

Feb 25, 2021 | 2:23 AM GMT

ICON plc (NASDAQ:ICLR) is buying fellow CRO PRA Health Sciences Inc. (NASDAQ:PRAH) in a cash and stock transaction valued at

Read the full 538 word article

How to gain access

Continue reading with a
two-week free trial.